NCT04164888View on ClinicalTrials.gov

Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

June 18, 2020

Study Completion Date

November 17, 2020

Conditions
Hypercholesterolemia
Interventions
DRUG

CIVI 007

hypercholesterolemia agent

Trial Locations (7)

32127

Research Site, Port Orange

32216

Research Site, Jacksonville

40213

Research Site, Louisville

44224

Research Site, Munroe Falls

45227

Research Site, Cincinnati

46260

Research Site, Indianapolis

78229

Research Site, San Antonio

Sponsors
All Listed Sponsors
lead

Civi Biopharma, Inc.

INDUSTRY